BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 18268392)

  • 1. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
    Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
    Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
    Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
    Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. House dust mites on skin, clothes, and bedding of atopic dermatitis patients.
    Teplitsky V; Mumcuoglu KY; Babai I; Dalal I; Cohen R; Tanay A
    Int J Dermatol; 2008 Aug; 47(8):790-5. PubMed ID: 18717857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
    Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
    J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].
    Pacor ML; Biasi D; Maleknia T
    Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.
    Novak N; Bieber T; Hoffmann M; Fölster-Holst R; Homey B; Werfel T; Sager A; Zuberbier T
    J Allergy Clin Immunol; 2012 Oct; 130(4):925-31.e4. PubMed ID: 22947344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites].
    Damps-Konstańska I; Gruchała-Niedoszytko M; Wilkowska A; Glén J; Konstański Z; Jassem E; Słomiński JM
    Pol Merkur Lekarski; 2005 Dec; 19(114):765-8. PubMed ID: 16521419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.
    Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].
    Pacor ML; Biasi D
    Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.
    Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P
    Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.